Skip to main content

Surmodics Inc

SRDXDelisted Nov 19, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000924717

Surmodics Inc was delisted on Nov 19, 2025; its insiders filed their last Form 4 on Nov 19, 2025; 146 institutions reported holding it in 13F filings for Q3 2025, worth $345.2M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Surmodics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Surmodics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Surmodics Inc
NameTitleLast reported holdingLast filingFilings, past year
Knight Susan EDirector0Nov 19, 20251
Bedoya Jose HDirector0Nov 19, 20251
Dantzker DavidDirector0Nov 19, 20251
Olson Charles WSVP, Medical Device Coatings0IndirectNov 19, 20251
Stich Joseph J.SVP of HR, President IVD0Nov 19, 20251
Arens Timothy J.Chief Financial Officer0Nov 19, 20251
Maharaj Gary RPresident & CEO0Nov 19, 20251
Heine Lisa WippermanDirector0Nov 19, 20251
Manders John D.VP Finance, Corp. Controller0Nov 19, 20251
Sides Teri WoodwickSVP, Vascular Interventions0Nov 19, 20251
Weber Gordon S.Sr. VP of Legal, GC and Sec.0Nov 19, 20251
Kalich Ronald B SrDirector38,278Feb 12, 20240
Sultana NusrathVP, Clinical Affairs6,530Feb 14, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 13, 2021 (view filing)Aug 112 daysManders John D.Corporate ControllerSSale−2.61K$53.35−$139.1K−45.6%3.11K after2 lots
Aug 23, 2021 (view filing)Aug 194 daysStich Joseph J.SVP, HR and GM, IVDSSale−2.50K$54.40−$136.0K−5.6%42.3K after
Sep 1, 2021 (view filing)Aug 311 dayOlson Charles WSenior VP of Bus Dev, Med DevSSale−1.29K$59.75−$77.2K−3.2%39.3K after
Sep 17, 2021 (view filing)Sep 152 daysMaharaj Gary RPresident & CEOSSale−6.00K$57.23−$343.4K−3.6%158.8K after2 lots
Oct 5, 2021 (view filing)Oct 14 daysMaharaj Gary RPresident & CEOSSale−6.00K$56.02−$336.1K−3.8%152.8K after2 lots
Nov 2, 2021 (view filing)Nov 11 dayMaharaj Gary RPresident & CEOSSale−6.00K$54.65−$327.9K−3.9%146.8K after2 lots
Nov 29, 2021 (view filing)Nov 245 daysDantzker DavidDirectorSSale−3.48K$47.01−$163.4K−10.1%30.8K after
Dec 1, 2021 (view filing)Nov 301 dayBedoya Jose HDirectorSSale−5.58K$44.00−$245.3K−19.6%22.8K after
Jan 6, 2022 (view filing)Jan 42 daysStich Joseph J.SVP, HR and GM, IVDSSale−2.50K$50.00−$125.0K−5.2%45.8K after
Mar 2, 2022 (view filing)Feb 282 daysKnight Susan EDirectorSSale−4.37K$44.97−$196.3K−12.6%30.2K after
Apr 5, 2022 (view filing)Apr 14 daysMaharaj Gary RPresident & CEOSSale−3.90K$44.97−$175.4K−2.5%155.1K after
Apr 5, 2022 (view filing)Apr 14 daysMaharaj Gary RPresident & CEOSSale−100$45.55−$4.55K−0.1%155.0K after
Nov 15, 2022 (view filing)Nov 141 dayDantzker DavidDirectorSSale−2.77K$33.00−$91.5K−7.5%34.2K after
Nov 15, 2022 (view filing)Nov 114 daysKalich Ronald B SrDirectorSSale−2.73K$33.48−$91.5K−8.3%30.2K after
Nov 30, 2022 (view filing)Nov 282 daysBedoya Jose HDirectorSSale−4.37K$34.89−$152.3K−15.3%24.2K after
Nov 27, 2024 (view filing)Nov 261 dayArens Timothy J.Chief Financial OfficerSSale−7.01K$39.44−$276.4K−9.1%70.3K after